metatools
SDTM supplemental-qualifier merging got sturdier, then the package went quiet for two years.
A side-by-side editorial comparison of serofoi and Rho — release velocity, themes, recent moves, and the top alternatives to consider.
serofoi grew a serosurvey simulator alongside the force-of-infection models it was built to fit.
serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.
Rho is building an agentic R IDE in public, one signed prerelease at a time.
Rho ships only development prereleases — a Windows build stamp in July, then two 0.4.0 candidates in August. The 0.4.0-dev.39 notes are the first to describe the product rather than the build: provider-first model settings with capability-based routing, project-scoped agent conversations with bounded concurrency and per-file Apply/Undo, and AGPL-3.0-only licensing. Release engineering gets as much text as features — signing, notarization, checksums, and an actor-bound acceptance record.
serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.
The package moved from fitting-only to a fit-and-simulate pair. 0.1.0 added simulation from time- or age-varying force-of-infection trends and simplified the fitted object down to a Stan fit; 1.0.2 broadened simulation into full serosurvey generation with its own vignette. 1.0.3 then spent its effort on naming consistency and plotting options, which is what a package does once its scope is set.
With simulation and fitting both in place, the natural next step is tooling that closes the loop between them — recovery checks or study-design guidance built on simulated surveys.
Rho ships only development prereleases — a Windows build stamp in July, then two 0.4.0 candidates in August. The 0.4.0-dev.39 notes are the first to describe the product rather than the build: provider-first model settings with capability-based routing, project-scoped agent conversations with bounded concurrency and per-file Apply/Undo, and AGPL-3.0-only licensing. Release engineering gets as much text as features — signing, notarization, checksums, and an actor-bound acceptance record.
The direction is an R IDE where a model-driven agent edits files under explicit user control, with the provider left open rather than bundled. Each release tightens the evidence chain around the binaries at least as hard as it tightens the feature set, and the notes name exactly which human checks were skipped and why. Nothing in the feed is presented as production-ready.
Expect the 0.4.0 line to keep iterating as dev builds until a Windows device and an enabled-Gatekeeper Mac clear the two outstanding human checks; a stable tag looks unlikely before that.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either serofoi or Rho.
SDTM supplemental-qualifier merging got sturdier, then the package went quiet for two years.
marquee is filling in the typographic details — outlines, border types, real font metrics for underlines.
A clinical-script logger that stopped shipping after its 0.2 line, changelogs made of merged PRs.
R's object inspector is losing its view of the internals as CRAN closes off the private C API.
A weather-station data client that broke one return type to hand back distances instead of bare IDs.
giscoR's 1.0 moved its dataset index into the cache, so new Eurostat releases arrive without a package update.
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. Rho is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Rho is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top serofoi alternatives in Analytics are ranked by recent ship velocity. Browse the "serofoi alternatives" section above for the current picks, or visit /alternatives/serofoi for the full list with editorial commentary on each.
Top Rho alternatives in Analytics are ranked by recent ship velocity. Browse the "Rho alternatives" section above for the current picks, or visit /alternatives/yulab-smu-rho for the full list with editorial commentary on each.